Request page removalAbout Francesco Rubertis
Francesco Rubertis is an entrepreneur, an angel investor and a board member based out of Geneva, Switzerland. They did their Doctoral from University of Geneva. Their journey in the startup ecosystem started in 2016 through Medicxi. Francesco Rubertis has founded 1 company. As an angel investor, Francesco Rubertis has a portfolio of 2 companies, focusing primarily on sectors like Enterprise Applications, Consumer and 1 more sector. They invest in companies across United Kingdom and Spain. Their most notable investments are Whalar and Velada. Francesco Rubertis is currently serving as a board member at Levicept. In the past, they have acted as a board member of SuperX.
Key Metrics
Francesco Rubertis' Investments
Francesco Rubertis has invested in 2 companies, which was in Velada (Seed Round) on Oct 05, 2022. Their investments are primarily in Enterprise Applications, Consumer and 1 more sector. Their investment portfolio include companies in United Kingdom and Spain.Here is the detail of this recent investment:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Oct 05, 2022 | Seed | $1.07M | - |
Want to explore profiles similar to Francesco Rubertis?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Francesco Rubertis' Portfolio Exits
Francesco Rubertis has 1 Portfolio Exit which is Whalar.
Here is the detail of this portfolio exit:
Company | Description | Location | Total Funding | Founded Year | Exit Type | Exit Date |
|---|---|---|---|---|---|---|
Social influencer marketplace for brands | London (United Kingdom) | - | 2016 | Acquisition | Jun 08, 2026 |
Francesco Rubertis' Founded Companies
Francesco Rubertis has founded Medicxi.
Here is the detail of this founded company:
Company | Short Description | Total Funding | Founded Year | Current Stage | Location |
|---|---|---|---|---|---|
Early-stage life science focused VC firm investing in geographies such as Europe and the US | - | 2016 | Unfunded | London |
Francesco Rubertis' Board Memberships
Francesco Rubertis has 1 current and 1 past board memberships namely Levicept and SuperX.Here is the detail of this board membership:
Company | Description | Total Funding | Current Stage | Membership Status | Appointment Date | Cessation Date |
|---|---|---|---|---|---|---|
Developer of therapeutics for the treatment of chronic pain | $50.9M | Series B | CURRENT | Nov 17, 2020 | - | |
UK-based, early-stage, funded biotech developing anticoagulation therapeutics without risk of bleeding | $11M | Series A | PAST | Jan 07, 2016 | Dec 14, 2016 |
FAQs about Francesco Rubertis
Recently updated other profiles
